Glass is a street name for crystal methamphetamine, a powerful stimulant that gets its nickname from its appearance: small, translucent fragments that look like shards of broken glass or shiny blue-white rocks. It is one of the most common forms of methamphetamine and is also widely known as “ice” or “crystal.” Glass is a Schedule II controlled substance, meaning it carries a high potential for abuse and dependence.
Why It’s Called Glass
Methamphetamine comes in several forms. In its basic versions, it’s a pill or powder. Crystal meth, the form referred to as glass, is chemically the same drug but has been processed into a crystalline structure that resembles small fragments of glass or translucent rocks of various sizes. The chunks can range from tiny grains to larger pieces, often with a blue-white tint. This distinctive look is what gave it the street names “glass,” “ice,” and “crystal.”
How Glass Affects the Brain
Glass works primarily by flooding the brain with dopamine, the chemical messenger tied to pleasure, motivation, and reward. Under normal conditions, nerve cells release dopamine and then reabsorb it through specialized recycling channels. Methamphetamine disrupts this system in two ways: it blocks those recycling channels so dopamine stays active longer, and it forces the channels to run in reverse, pushing even more dopamine out of nerve cells and into the surrounding space.
The result is an intense surge of euphoria, energy, and confidence that can last 8 to 12 hours, far longer than most stimulants. This massive dopamine release is what makes glass so powerfully reinforcing. The brain quickly begins associating the drug with an overwhelming reward signal, which drives repeated use.
Immediate Physical Effects
Glass ramps up the body’s metabolism and activates the sympathetic nervous system, producing a range of acute physical responses. Heart rate and blood pressure spike. Body temperature rises, sometimes dangerously. The drug also constricts blood vessels, which traps heat inside the body and limits the ability to cool down. Brain cells are especially vulnerable to temperature changes, and irreversible damage can begin when brain temperature climbs just three degrees above its normal baseline, to around 40°C (104°F).
Other common short-term effects include loss of appetite, dilated pupils, jaw clenching, rapid breathing, and a sense of heightened alertness. Users often stay awake for extended periods, sometimes days at a time, which compounds the physical stress on the body.
Psychosis and Hallucinations
Transient psychotic symptoms, including paranoia, visual or auditory hallucinations, and delusions, appear in up to 40% of methamphetamine users. These episodes can look strikingly similar to schizophrenia. In most cases, symptoms resolve within about a week of stopping the drug. When hallucinations or delusions persist for more than a month after the last use, clinicians consider the possibility that a separate psychotic disorder has been unmasked or triggered.
The intensity of psychotic symptoms tends to increase with higher doses, longer binges, and sleep deprivation. Paranoia is particularly common and can lead to agitation or aggressive behavior during intoxication.
Long-Term Brain Damage
Chronic use of glass causes lasting damage to the brain’s dopamine and serotonin systems. The areas most affected include the striatum (involved in movement and reward), the prefrontal cortex (responsible for decision-making and impulse control), and the hippocampus (critical for memory). Over time, the nerve endings in these regions deteriorate, leading to persistent problems with concentration, emotional regulation, and the ability to experience pleasure from everyday activities.
Some of this damage is partially reversible with sustained abstinence, but recovery is slow and often incomplete. People who are also living with HIV face compounded risk, as the virus and methamphetamine appear to work together to worsen dysfunction in the brain’s reward and movement centers.
Dental Decay and Skin Damage
The severe tooth decay known as “meth mouth” is one of the most visible signs of long-term glass use. For years, the leading theory was that acidic chemicals in the drug directly corroded tooth enamel. Research published in the Journal of the American Dental Association tells a more nuanced story. The drug dries out the mouth significantly, a condition called xerostomia. To relieve that constant dry sensation, users tend to sip sugary soft drinks throughout the day. Combined with poor dental hygiene during long periods of use, this creates ideal conditions for rampant cavities. Notably, researchers found that smoking glass did not cause worse dental damage than snorting or injecting it, which undermines the idea that the smoke itself is the primary culprit.
Skin sores are another hallmark. Users frequently pick at their skin due to a crawling sensation (sometimes called “meth mites”), and the combination of compulsive picking, poor nutrition, reduced blood flow, and weakened immune function leads to open wounds that heal slowly.
Withdrawal Timeline
Withdrawal from glass follows a two-phase pattern. The acute phase lasts roughly 7 to 10 days. Symptoms peak about 24 hours after the last dose and include intense cravings, depression, extreme fatigue, increased appetite, and vivid, unpleasant dreams. Some people experience joint pain, headaches, irritability, and red or itchy eyes during this phase.
A subacute phase follows, lasting up to an additional two to three weeks. Symptoms during this period are milder and more stable, but cravings remain a persistent challenge. In studies tracking withdrawal patterns, craving did not begin to decrease significantly until the second week of abstinence and continued at a reduced level through at least the fifth week. Depression and psychotic symptoms, by contrast, largely resolved within the first week.
Treatment Options
There is currently no approved medication specifically for methamphetamine addiction. Treatment relies on behavioral therapies, and the most effective of these is contingency management. This approach provides tangible rewards, typically monetary vouchers, for consecutive drug-free urine tests. Of 27 studies evaluating contingency management for methamphetamine dependence, 26 found it effectively reduced use. Benefits extended beyond abstinence to include better treatment retention, fewer psychiatric symptoms, and reductions in risky behavior. Evidence also shows that these effects can persist months after treatment ends.
Cognitive-behavioral therapy and the Matrix Model (a structured 16-week outpatient program combining group therapy, individual counseling, drug education, and family involvement) are also used. Interestingly, combining contingency management with other therapies has not shown additive benefits in research settings, suggesting that the reward-based approach may be doing most of the heavy lifting on its own.